Non-competitive, open-channel NMDA receptor blockers are used for Alzheimer's and depression management, improving brain disorders through neurostructural changes and synaptic plasticity.
Antagonizing NMDA receptors in different brain regions can either increase or decrease food intake, with prolonged administration leading to anorexia and weight loss in rodents.
[
add
]
[
|
|
...
]